Your browser doesn't support javascript.
loading
International Liver Cancer Association (ILCA) White Paper on Biomarker Development for Hepatocellular Carcinoma.
Singal, Amit G; Hoshida, Yujin; Pinato, David J; Marrero, Jorge; Nault, Jean-Charles; Paradis, Valerie; Tayob, Nabihah; Sherman, Morris; Lim, Young Suk; Feng, Ziding; Lok, Anna S; Rinaudo, Jo Ann; Srivastava, Sudhir; Llovet, Josep M; Villanueva, Augusto.
Afiliação
  • Singal AG; Division of Digestive and Liver Diseases, Department of Internal Medicine, UT Southwestern Medical Center, Dallas, Texas, Texas. Electronic address: amit.singal@utsouthwestern.edu.
  • Hoshida Y; Division of Digestive and Liver Diseases, Department of Internal Medicine, UT Southwestern Medical Center, Dallas, Texas, Texas.
  • Pinato DJ; Department of Surgery & Cancer, Imperial College London, Hammersmith Hospital, London, UK.
  • Marrero J; Division of Digestive and Liver Diseases, Department of Internal Medicine, UT Southwestern Medical Center, Dallas, Texas, Texas.
  • Nault JC; Service d'hépatologie, Hôpital Jean Verdier, Hôpitaux Universitaires Paris-Seine-Saint-Denis, Assistance-Publique Hôpitaux de Paris, Bondy, France; Unité de Formation et de Recherche Santé Médecine et Biologie Humaine, Université Paris 13, Paris, France; Centre de Recherche des Cordeliers, Inserm, S
  • Paradis V; Pathology Department, Beaujon hospital, Clichy, University Paris, France.
  • Tayob N; Department of Data Science, Dana Farber Cancer Institute, Department of Medicine, Harvard Medical School, Boston, Massachusetts.
  • Sherman M; University Health Network, Toronto, Ontario, Canada.
  • Lim YS; Department of Gastroenterology, Liver Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
  • Feng Z; Biostatistics Program, Public Health Science Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Lok AS; Division of Gastroenterology and Hepatology, University of Michigan, Ann Arbor, Michigan.
  • Rinaudo JA; Cancer Biomarker Research Group, Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Rockville, Maryland.
  • Srivastava S; Cancer Biomarker Research Group, Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Rockville, Maryland.
  • Llovet JM; Division of Liver Diseases and Hematology/Medical Oncology, Liver Cancer Program, Tisch Cancer Institute, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York; Translational Research in Hepatic Oncology, Liver Unit, IDIBAPS, Hospital Clinic, University of Barcelona, Ca
  • Villanueva A; Division of Liver Diseases and Hematology/Medical Oncology, Liver Cancer Program, Tisch Cancer Institute, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York. Electronic address: augusto.villanueva@mssm.edu.
Gastroenterology ; 160(7): 2572-2584, 2021 06.
Article em En | MEDLINE | ID: mdl-33705745

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Biomarcadores Tumorais / Carcinoma Hepatocelular / Medição de Risco / Detecção Precoce de Câncer / Neoplasias Hepáticas Tipo de estudo: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Biomarcadores Tumorais / Carcinoma Hepatocelular / Medição de Risco / Detecção Precoce de Câncer / Neoplasias Hepáticas Tipo de estudo: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article